| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/17/2000 | EP1000160A1 CLONING OF THE PROLYL-DIPEPTIDYL-PEPTIDASE FROM $i(ASPERGILLUS ORYZAE) |
| 05/17/2000 | EP1000159A1 Starch debranching enzymes |
| 05/17/2000 | EP1000151A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 05/17/2000 | EP1000150A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
| 05/17/2000 | EP1000149A2 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 05/17/2000 | EP1000148A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
| 05/17/2000 | EP1000147A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 05/17/2000 | EP1000145A1 Heart and skeleton muscle specific nucleic acid, the production and use thereof |
| 05/17/2000 | EP1000089A1 Collagen type i and type iii adhesive compositions |
| 05/17/2000 | EP1000087A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 05/17/2000 | EP0934425A4 Renilla luciferase and green fluorescent protein fusion genes |
| 05/17/2000 | EP0574461B1 High affinity humanized monoclonal antibodies |
| 05/17/2000 | CN1253589A Human complement C3-degrading proteinase from streptococcus pneumoniae |
| 05/17/2000 | CN1253567A Cell surface molecule mediating cell adhesion and signal transmission |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/17/2000 | CN1052510C Mammalian receptors for interleukin-10 |
| 05/16/2000 | US6063905 Recombinant human IGA-J. chain dimer |
| 05/16/2000 | US6063904 Isolated envelope protein with an amino acid sequence deletion; for efficient recombinant expression; for vaccines; for diagnostic reagents |
| 05/16/2000 | US6063903 Ligands for EPH-like receptors |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063766 Drugs and proteins from blood with amino acid sequences |
| 05/16/2000 | US6063763 Enzyme inhibitors |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063756 Insecticidal polypeptides |
| 05/16/2000 | US6063623 Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, DNA sequences encoding it and their use |
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063609 Expression vector comprising an enzymatic protein; for use as diagnostic tools as well as antiarthritic, antiproliferative, anticarcinogenic, antitumor and antiinflammatory agents |
| 05/16/2000 | US6063601 Chimaeric gene coding for a transit peptide and a heterologous peptide |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063593 TGFβ1 responsive bone marrow derived cells to express a recombinant protein |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063409 Species cryptococcus nodaensis, a process for producing salt-resistant thermostable glutaminase by use of the same, and a process for producing glutamic acid-rich protein hydrolysates |
| 05/16/2000 | CA2131826C Mn gene and protein |
| 05/16/2000 | CA2090701C Solubilization of proteins in active forms |
| 05/16/2000 | CA1340992C Process for the production of recombinant porcine growth hormone polypeptides |
| 05/11/2000 | WO2000026671A1 Detection of acid-resistant micro-organisms in a stool |
| 05/11/2000 | WO2000026668A2 S100 proteins and autoantibodies as serum markers for cancer |
| 05/11/2000 | WO2000026667A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/11/2000 | WO2000026418A1 Human pan-hcv human monoclonal antibodies |
| 05/11/2000 | WO2000026407A1 Method for determining cancer by determining expression of mage-10 |
| 05/11/2000 | WO2000026394A1 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 05/11/2000 | WO2000026383A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | WO2000026382A1 Thioredoxin reductase ii |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026358A1 Selenocysteine insertion sequence |
| 05/11/2000 | WO2000026354A1 Glycosylated proteins having reduced allergenicity |
| 05/11/2000 | WO2000026352A1 Novel trypsin family serine proteases |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026344A1 Peptides with enhanced stability to protease degradation |
| 05/11/2000 | WO2000026255A1 Anti-petasin antibodies, methods for the production thereof and their use |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026246A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026241A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | WO2000026240A2 Streptococcal alpha2m-binding protein |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026238A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026230A1 Low allergenic protein variants |
| 05/11/2000 | WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | WO2000025805A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
| 05/11/2000 | WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000008164A3 Thermostable in vitro complex with polymerase activity |
| 05/11/2000 | WO2000008158A3 Molecules designated ldcam |
| 05/11/2000 | WO2000008043A3 Prevention and treatment of viral disease |
| 05/11/2000 | WO1999066956A9 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP) |
| 05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
| 05/11/2000 | WO1999027100A9 Fibroblast growth factor-19 |
| 05/11/2000 | DE19852903A1 Katalytische Antikörper und ein Verfahren zur Herstellung von Chromanen über Zyklisierung mit diesen Antikörpern Catalytic antibody and a process for producing chromans on cyclization with these antibodies |
| 05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | CA2349593A1 S100 proteins and autoantibodies as serum markers for cancer |
| 05/11/2000 | CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2349428A1 Alpha 1,2-fucosyltransferase from helicobacter pylori |
| 05/11/2000 | CA2349410A1 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 05/11/2000 | CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | CA2348938A1 Low allergenic protein variants |
| 05/11/2000 | CA2348822A1 Glycosylated proteins having reduced allergenicity |
| 05/11/2000 | CA2348777A1 Rotavirus subunit vaccine |
| 05/11/2000 | CA2348756A1 Enhanced vaccines |
| 05/11/2000 | CA2348751A1 Biological materials and methods useful in the diagnosis and treatment of diseases |
| 05/11/2000 | CA2348733A1 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 05/11/2000 | CA2348421A1 Protein |
| 05/11/2000 | CA2347650A1 Transmembrane 4 proteins |
| 05/11/2000 | CA2317808A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 05/10/2000 | EP0999470A1 Gelatin |
| 05/10/2000 | EP0999284A1 Method for screening antimycotic substances using essential genes from c.albicans, and said genes |
| 05/10/2000 | EP0999281A1 Non-nuclear chromosomal transformation |